• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[ⅢA期霍奇金淋巴瘤放化疗效果评估]

[Evaluation of the effectiveness of chemoradiotherapy of stage IIIA Hodgkin's disease].

作者信息

Kanaev S V, Gershanovich M L, Malinin A P, Kholin A V

出版信息

Med Radiol (Mosk). 1987 May;32(5):16-21.

PMID:3586917
Abstract

A total of 106 case histories of primary patients with stage III Hodgkin's disease aged 15 and older were analyzed. The treatment consisted of 2 introductory courses of polychemotherapy after MOPP scheme followed by a radical program of radiotherapy in 2-4 weeks, resulting in 88.7% of complete remissions. The 5-year survival rate was 81.3-6.3%, a 5-year recurrence-free course was noted in 83.8-5.2%. The 5-year survival rate was significantly lower in the patients with "unfavorable" histological types (mixed cellular and lymphoid depletion). A recurrence-free course over the same period was worse in men than in women, and in the patients with 5 and more zones of involvement.

摘要

对106例年龄在15岁及以上的Ⅲ期霍奇金病初治患者的病历进行了分析。治疗方案为在MOPP方案基础上进行2个周期的诱导多药化疗,随后在2 - 4周内进行根治性放疗,完全缓解率达88.7%。5年生存率为81.3 - 6.3%,5年无复发生存率为83.8 - 5.2%。组织学类型为“不良”(混合细胞型和淋巴细胞消减型)的患者5年生存率显著较低。同期男性的无复发生存情况比女性差,且受累区域为5个及以上的患者也是如此。

相似文献

1
[Evaluation of the effectiveness of chemoradiotherapy of stage IIIA Hodgkin's disease].[ⅢA期霍奇金淋巴瘤放化疗效果评估]
Med Radiol (Mosk). 1987 May;32(5):16-21.
2
[Comparative evaluation of the efficacy of chemotherapy and chemoradiotherapy of stage IIIB Hodgkin's disease].[ⅢB期霍奇金淋巴瘤化疗与放化疗疗效的比较评估]
Vopr Onkol. 1988;34(4):438-45.
3
[Role of radiotherapy in the treatment of stage IIIB Hodgkin's disease in children].[放射治疗在儿童ⅢB期霍奇金病治疗中的作用]
Med Radiol (Mosk). 1987 May;32(5):13-5.
4
[The role of radiotherapy in the treatment of Stage IIIA Hodgkin's disease in children].[放射治疗在儿童ⅢA期霍奇金病治疗中的作用]
Vopr Onkol. 1986;32(9):53-6.
5
[The role of radiotherapy in the treatment of Hodgkin's disease].
Gan No Rinsho. 1985 Dec;31(15):1899-904.
6
The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.一项病例对照研究表明,接受霍奇金淋巴瘤联合治疗方案的患者发生急性白血病的风险显著高于单纯接受化疗的患者,且该风险与放疗范围、化疗类型及疗程相关。
Haematologica. 1998 Sep;83(9):812-23.
7
[The role of radiotherapy in the treatment of stage I-II Hodgkin's disease in children].[放射治疗在儿童I-II期霍奇金病治疗中的作用]
Med Radiol (Mosk). 1986 Jul;31(7):14-8.
8
Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.临床I期或II期霍奇金淋巴瘤的综合治疗:欧洲癌症研究与治疗组织H7随机对照试验的长期结果
J Clin Oncol. 2006 Jul 1;24(19):3128-35. doi: 10.1200/JCO.2005.05.2746. Epub 2006 Jun 5.
9
Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.单纯化疗或综合治疗小儿霍奇金病
Radiat Oncol Investig. 1999;7(6):365-73. doi: 10.1002/(SICI)1520-6823(1999)7:6<365::AID-ROI7>3.0.CO;2-W.
10
[Prognostic factors in the chemoradiation treatment of III-stage lymphogranulomatosis].[III 期淋巴肉芽肿病放化疗的预后因素]
Med Radiol (Mosk). 1988 Jul;33(7):40-6.